The slow release of BMP-7 at a low dose accelerates dental implant healing in an osteopenic environment.

Hunziker, E. B.; Liu, Y.; Muff, M.; Haegi, T.; Shintani, N.; Lippuner, K. (2021). The slow release of BMP-7 at a low dose accelerates dental implant healing in an osteopenic environment. European cells & materials eCM, 41, pp. 170-183. University of Wales 10.22203/eCM.v041a12

[img]
Preview
Text
v041a12.pdf - Published Version
Available under License Creative Commons: Attribution-Share Alike (CC-BY-SA).

Download (882kB) | Preview

The aim of the present study was to investigate in vivo whether bone morphogenetic protein-7 (BMP-7) was able to promote and accelerate dental implant healing at a low dose in an osteopenic environment by using a delayed drug-release system. Skeletally mature Chinese goats, having physiologically osteopenic (osteoporotic-like) facial bones, served as an animal model. Dental implants were provided with a delayed-release drug-delivery system and BMP-7 was applied at three different dosages. The implants, inserted into healed extraction sockets, were removed 1, 2 and 3 weeks after surgery. Quantification of osseointegration and formation of new bone in the peri- implant space were measured histomorphometrically. Data revealed no evidence of any adverse drug effect at or near the implantation sites. After the first postoperative week, bone neoformation was minimal; after the second week, peri-implant bone formation appeared, particularly in the groups with low dosages of BMP-7. After 3 weeks, new-bone volume was the largest in the group with the lowest (near-physiological) dosage of BMP-7, also showing the highest efficacy of BMP-7. Other dosage or release modes were found to be significantly less effective. BMP-7 was highly efficacious in promoting and accelerating bone formation in the peri-implant space in a hostile osteopenic environment if released by a slow-mode mechanism over time at near physiological activities. Therefore, biological functionalisation of dental implants by a high-power osteogenic factor may improve their healing success in hostile bony environments (osteopenia, osteoporosis, bone atrophy etc.).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Orthopaedic Surgery

UniBE Contributor:

Hunziker, Ernst Bruno, Liu, Yuelian, Lippuner, Kurt

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1473-2262

Publisher:

University of Wales

Language:

English

Submitter:

Kathrin Aeschlimann

Date Deposited:

10 Nov 2021 17:19

Last Modified:

05 Dec 2022 15:53

Publisher DOI:

10.22203/eCM.v041a12

PubMed ID:

33580967

BORIS DOI:

10.48350/160117

URI:

https://boris.unibe.ch/id/eprint/160117

Actions (login required)

Edit item Edit item
Provide Feedback